Long-term management of prolactinomas.
Prolactinomas are a frequent cause of gonadal dysfunction and infertility, especially in young women. The regulation of prolactin secretion and the efficacy of dopamine agonists in the therapy of prolactinomas are well established. The current challenges in management of prolactinomas are related to follow-up after successful therapy. Issues and questions to be addressed in this approach to long-term management of prolactinomas include the frequency of radiographic monitoring, effect of pregnancy and menopause, safety of estrogen in women taking oral contraceptives, and the potential for discontinuation of dopamine agonist therapy.
Department of Internal Medicine, 157 MRF, University of Iowa Hospital, 200 Hawkins Drive, Iowa City, Iowa 52242, USA. janet-schlechte@uiowa.edu
Janet A
JA
Schlechte
D000328:Adult; D000568:Amenorrhea / Q000209:etiology; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D005687:Galactorrhea / Q000209:etiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008593:Menopause / Q000502:physiology; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy*; D011247:Pregnancy; D015175:Prolactinoma / Q000150:complications / Q000473:pathology / Q000628:therapy*
D003278:Contraceptives, Oral, Hormonal; D018491:Dopamine Agonists; D004967:Estrogens